Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia

Brain Research

Volumn 816, Issue 2, 1999, Pages 299-308

  Arias, Robert L ^a   Tasse, J René P ^a   Bowlby, Mark R ^a  

^a PFIZER INC   (United States)

Author keywords

AMPA; Anoxia; Glutamate; Ischemia; Neuroprotection; NMDA

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN SLICE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; EXTRACELLULAR CALCIUM; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANOXIA; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; BRAIN ISCHEMIA; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NEUROPROTECTIVE AGENTS; PIPECOLIC ACIDS; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0344299274     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01051-8     Document Type: Article

References (43)

1. Aitken P.G., Breese G.R., Dudek F.F., Edwards F., Espanol M.T., Larkman P.M., Lipton P., Newman G.C., Nowak T.S., Panizzon K.L., Raley-Susman K.M., Reid K.H., Rice M.E., Sarvey J.M., Schoepp D.D., Segal M., Taylor C.P., Teyler T.J., Voulalas P.J. Preparative methods for brain slices: a discussion. J. Neurosci. Methods. 59:1995;139-149.
2. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
3. Bahr B.A. Long-term hippocampal slices: a model system for investigating synaptic mechanisms and pathologic processes. J. Neurosci. Res. 42:1995;294-305.
4. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal death. TINS. 18:1995;58-60.
5. Choi D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6:1996;667-672.
6. Choi D.W. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc. Brain Metab. Rev. 2:1990;105-147.
7. D.W. Choi, NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation, in: K. Kogure, K.-A. Hossmann, B.K. Siesjö (Eds.), Progress in Brain Research, Vol. 96, Elsevier, 1993, pp. 137-143.
8. Dong W.-Q., Schurr A., Reid K.H., Shields C.B., West C.A. The rat hippocampal slice preparation as an in vitro model of ischemia. Stroke. 19:1988;498-502.
9. Globus M.Y.-T., Busto R., Dietrich W.D., Martinez E., Valdes I., Ginsberg M.D. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and λ-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51:1988;1455-1464.
10. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
11. Iino M., Ozawa S., Tsuzuki K. Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J. Physiol. 424:1990;151-165.
12. Izumi Y., Benz A.M., Kurby C.O., Labruyere J., Zorumski C.F., Price M.T., Olney J.W. An ex vivo rat retinal preparation for excitotoxicity studies. J. Neurosci. Methods. 60:1995;219-225.
13. Kaku D.A., Goldberg M.P., Choi D.W. Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose. Brain Res. 554:1991;344-347.
14. Kalloniatis M. Amino acids in neurotransmission and disease. J. Am. Optom. Assoc. 66:1995;750-757.
15. Kawasaki-Yatsugi S., Yatsugi S., Koshiya K., Shimizu-Sasamata M. Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats. Jpn. J. Pharmacol. 74:1997;253-260.
16. Lerma J. Kainate reveals its targets. Neuron. 19:1997;1155-1158.
17. Lipton P., Aitken P.G., Dudek F.E., Eskessen M.T., Espanol M.T., Ferchmin P.A., Kelly J.B., Kreisman N.R., Landfield P.W., Larkman P.M., Leybaert L., Newman G.C., Panizzon K.L., Payne R.S., Phillips P., Raley-Susman K.M., Rice M.E., Santamaria R., Sarvey J.M., Schurr A., Segal M., Sejer V., Taylor C.P., Teyler T.J., Vasilenko V.Y., Veregge S., Wu S.H., Wallis R. Making the best of brain slices: comparing preparative methods. J. Neurosci. Methods. 59:1995;151-156.
18. Lipton P., Whittingham T.S. Reduced ATP concentration as a basis for synaptic transmission failure during hypoxia in the in vitro guinea-pig hippocampus. J. Physiol. 325:1982;51-65.
19. Lobner D., Lipton P. Intracellular calcium levels and calcium fluxes in the CA1 region of the rat hippocampal slice during in vitro ischemia: relationship to electrophysiological cell damage. J. Neurosci. 13:1993;4861-4871.
20. Minervini M., Atlante A., Gagliardi S., Ciotti M.T., Marra E., Calissano P. Glutamate stimulates 2-deoxyglucose uptake in rat cerebellar granule cells. Brain Res. 768:1997;57-62.
21. 2+ and energy levels during in vitro ischemia in the gerbil hippocampal slice. J. Neurochem. 62:1994;626-634.
22. Muir K.W., Lees K.R. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 26:1995;503-513.
23. Newell D.W., Barth A., Papermaster V., Malouf A.T. Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J. Neurosci. 15:1995;7702-7711.
24. O'Byrne M., Tipton K., McBean G., Kollegger H. Assessment of neurotoxicity and neuroprotection. J. Neural. Transm. Suppl. 50:1997;153-164.
25. Ohmori J., Sakamoto S., Kubota H., Shimizu-Sasamata M., Okada M., Kawasaki S., Hidaka K., Togami J., Furuya T., Murase K. 6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor. J. Med. Chem. 37:1994;467-475.
26. Portera-Cailliau C., Price D.L., Martin L.J. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. 378:1997;88-104.
27. Pringle A.K., Iannotti F., Wilde G.J.C., Chad J.E., Seeley P.J., Sundstrom L.E. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res. 755:1997;36-46.
28. Robinson M.B., Dowd L.A. Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system. Adv. Pharmacol. 37:1997;69-115.
29. Rogawski M.A. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14:1993;325-331.
30. Rogers D.C., Hunter A.J. Dissociation of effects of glutamate receptor antagonists on excitotoxic and hypoxic neuronal cell death in a novel rat cortical culture system. Brain Res. Bull. 44:1997;131-139.
31. 2+-independent release of glutamate during in vitro anoxia in isolated nerve terminals. J. Neurochem. 57:1991;1159-1164.
32. Rudolph J.G., Lemasters J.J., Crews F.T. Use of a multiwell fluorescence scanner with propidium iodide to assess NMDA-mediated excitotoxicity in rat cortical neuronal cultures. Neurosci. Lett. 221:1997;149-152.
33. Schoepp D.D., Salhoff C.R., Fuson K.S., Sacaan A.I., Tizzano J.P., Ornstein P.L., May P.C. Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3- carboxylic acid (LY293558) and its racemate (LY215490). J. Neural. Transm. 103:1996;905-916.
34. A. Schurr, P. Lipton, C.A. West, B.M. Rigor, The role of energy metabolism and divalent cations in the neurotoxicity of excitatory amino acids in vitro, in: J. Krieglstein, H. Oberpichler (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsellchaft, Stuttgart, 1990.
35. Schurr A., Payne R.S., Heine M.F., Rigor B.M. Hypoxia, excitotoxicity, and neuroprotection in the hippocampal slice preparation. J. Neurosci. Methods. 59:1995;129-138.
36. Schurr A., Payne R.S., Rigor B.M. Protection by MK-801 against hypoxia-, excitotoxin-, and depolarization-induced neuronal damage in vitro. Neurochem. Int. 26:1995;519-525.
37. Shiraishi K. A new non-NMDA antagonist modifies the local cerebral glucose utilization in kainate-induced generalized seizure. Neurol. Res. 19:1997;545-550.
38. Siesjö B.K., Katsura K., Zhao Q., Folbergrova J., Pahlmark K., Siesjö P., Smith M.L. Mechanisms of secondary brain damage in global and focal ischemia: a speculative hypothesis. J. Neurotrauma. 12:1995;943-956.
39. Sochocka E., Juurlink B.H.J., Code W.E., Hertz V., Peng L., Hertz L. Cell death in primary cultures of mouse neurons and astrocytes during exposure to and recovery from hypoxia, substrate deprivation and simulated ischemia. Brain Res. 638:1994;21-28.
40. Strasser U., Fischer G. Protection from neuronal damage induced by combined oxygen and glucose deprivation in organotypic hippocampal cultures by glutamate receptor antagonists. Brain Res. 687:1995;167-174.
41. Szatkowski M., Attwell D. Triggering and execution of neuronal death in brain ischemia: two phases of glutamate release by different mechanisms. TINS. 17:1994;359-365.
42. Taylor C.P., Burke S.P., Weber M.L. Hippocampal slices: glutamate overflow and cellular damage from ischemia are reduced by sodium-channel blockade. J. Neurosci. Methods. 59:1995;121-128.
43. Whittingham T.S., Assaf H., Selman W.R., Ratcheson R.A., Lust W.D. Glutamate-induced energetic stress in hippocampal slices: evidence against NMDA and glutamate uptake as mediators. Metab. Brain Dis. 7:1992;77-92.